Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Citi
UBS
Express Scripts
Deloitte
Harvard Business School

Generated: August 26, 2019

DrugPatentWatch Database Preview

Litigation Details for Gilead Sciences, Inc. v. Lupin Limited (S.D.N.Y. 2012)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Gilead Sciences, Inc. v. Lupin Limited (S.D.N.Y. 2012)

Docket ➤ Sign Up Date Filed 2012-08-16
Court District Court, S.D. New York Date Terminated 2014-09-17
Cause 35:271 Patent Infringement Assigned To Richard Joseph Sullivan
Jury Demand Defendant Referred To
Parties EMORY UNIVERSITY; GILEAD SCIENCES, INC.,; LUPIN LIMITED
Patents 5,814,639; 5,914,331; 6,703,396
Attorneys Adam Charles Larock; Christopher P. Borello; Colleen Tracy James; Deanne M. Mazzochi; Jason Elton Johnson; Jill Catherine Owens; Mary Regina Phillips; Nicholas M. Cannella; Paul John Molino; Peter DeForest Shapiro; Peter J. Curtin; Roy Chamcharas; William Andrew Rakoczy
Firms Fitzpatrick, Cella, Harper & Scinto(NYC)
Link to Docket External link to docket
Small Molecule Drugs cited in Gilead Sciences, Inc. v. Lupin Limited
The small molecule drugs covered by the patents cited in this case are ➤ Sign Up , ➤ Sign Up , ➤ Sign Up , ➤ Sign Up , ➤ Sign Up , ➤ Sign Up , ➤ Sign Up , ➤ Sign Up , ➤ Sign Up , and ➤ Sign Up .

Details for Gilead Sciences, Inc. v. Lupin Limited (S.D.N.Y. 2012)

Date Filed Document No. Description Snippet Link To Document
2013-09-04 37 AND AGREEMENT REGARDING U.S. PATENT NOS. 6,703,396, 6,642,245, 5,814,639 AND 5,914,331: NOW THEREFORE:…13, 15 and 16 of the '396 Patent, (b) claims 1, 2, 4, and 6 of the '245 Patent, and (c) claims 1 and 2 …2 of the '639 Patent (all foregoing Claims of the '396, '245, and '639 Patents are collectively referred… 17 September 2014 1:12-cv-06293 830 Patent Defendant District Court, S.D External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Julphar
Harvard Business School
Colorcon
Fuji
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.